1384 Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy and significantly increases B-cell response in syngeneic liver Hepa1-6 tumor microenvironment

Autor:	Michel Janicot, Katrin Rupalla, Alexej Schmidt, Iris Helfrich, Bernhard B Singer
Rok vydání:	2022
Zdroj:	Regular and Young Investigator Award Abstracts.
DOI:	10.1136/jitc-2022-sitc2022.1384
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::da0f83e51aea1bd5662d25aa5c64e695 https://doi.org/10.1136/jitc-2022-sitc2022.1384 Zobrazit plný text záznamu